Picture
SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare

PUBLISHER: Greystone Research Associates | PRODUCT CODE: 1872364

Cover Image

PUBLISHER: Greystone Research Associates | PRODUCT CODE: 1872364

Self-Administered On-Body Subcutaneous Infusion Systems - Devices, Markets, Players and Forecasts

PUBLISHED:
PAGES: 72 Pages
DELIVERY TIME: 1-2 business days
SELECT AN OPTION
PDF (Single User License)
USD 3850
PDF (Site License)
USD 4500
PDF (Enterprise License)
USD 6500

Add to Cart

Self-administered On-Body Subcutaneous Infusion is a comprehensive evaluation and analysis of the technology, products and participants providing the driving force behind this evolving segment of the healthcare sector. The study is designed to provide drug company decision makers, drug delivery developers, device designers, healthcare marketers, and supply chain participants with a detailed understanding of the economics, technologies, disease segments, and commercial opportunities for devices that can self-administer injectable/infusible drugs subcutaneously at the point-of-care. Provider organization business managers, healthcare administrators and investors will also benefit from this study.

Converging Factors Driving the Growth of Subcutaneous Infusion

As prefilled devices continue to replace vials in terms of doses as well as total sector revenue, pharmaceutical and biotech program managers are increasingly integrating syringe and self-injection device technology into their development plans. The result has been a migration toward multi-functional development teams and an increasing reliance on accelerated product feasibility testing.


What You Will Learn:

  • What ambulatory subcutaneous infusion systems are currently marketed or in development, who are the suppliers, and what are the device specifics?
  • What are the therapeutic markets being targeted by ambulatory subcutaneous infusion systems?
  • What are the essential design factors, material selection issues, technologies and market development issues for ambulatory subcutaneous infusion systems?
  • What are the major factors that will drive ambulatory subcutaneous infusion systems demand?
  • What is the addressable market for subcutaneous infusion systems?
  • What is the expected impact of subcutaneous infusion systems on drug delivery markets?
  • Who are the significant players in this segment? What are their strategies? Who are their alliance partners?

Methodology

Research methodology is based on primary research in the form of in-depth interviews with key market participants, technology developers, distributors, industry experts, and market influencers, a list that includes regulatory officials, industry trade groups, and materials standards organizations.

Primary data is evaluated and normalized against secondary sources including trade journal articles, technical literature, industry publications, company data sheets and published information, and statistical data from government agencies and trade associations.

Forecasts and projections of market demand and future market activity are derived using standard modeling and statistical techniques.

Table of Contents

Executive Summary

  • A Comprehensive Assessment
  • Contents
  • Executive Summary
  • Injectable/Infusible Market Segment Dynamics
  • Drug Development Trends
  • Drug Delivery Device Evolution
  • The Trend toward Patient Self-Administration
  • Enabling Technology
  • Lyophilized Drugs/Reconstitution
  • Subcutaneous Infusion Systems - Design Factors
  • Volumes and Viscosities
  • Primary Packaging
  • Injection Method
  • Device Electronics
  • Subcutaneous Infusion Devices - Market Segments
  • The Cost and Logistical Burden of Out-patient Infusion
  • Biologicals
  • High Volume Drugs
  • Duration Dependent Administration Drugs
  • Subcutaneous Infusion Systems Device Analysis
  • enFuse (Enable Injections)
  • Libertas (Becton Dickinson)
  • Evolve (Becton Dickinson)
  • SensePatch (Sensile Medical/Gerresheimer)
  • SmartDose (West Pharmaceuticals
  • SmartDose Preloaded (West Pharmceuticals)
  • Unbranded Device (Sorrel Medical)
  • Unbranded Device (Subcuject)
  • YpsoDose (Ypsomed)
  • E3D Patch Pump (Elcam)
  • Pod (Stevanato)
  • Market Factors
  • Self-Administration and Patient Compliance
  • Regulatory Guidance and Product Approvals
  • Healthcare Economics
  • Drug Product Differentiation
  • Market Participant Profiles
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Hi, how can we help?
Contact us!